Luteolin is effective in the non‐small cell lung cancer model with<scp>L</scp>858<scp>R</scp>/<scp>T</scp>790<scp>M EGF</scp>receptor mutation and erlotinib resistance

Zhuan Hong(Jiangsu Cancer Hospital), Lan Luo(The First Affiliated Hospital of Guangxi University of Traditional Chinese Medicine), Xiaolong Pan(Nanjing Normal University), Lei Lan(Zhejiang Hospital), Yi Zhou(University of Electronic Science and Technology of China), Na Li(Macau University of Science and Technology), Yizhou Zhang(Nanjing University of Information Science and Technology), Zhimin Yin(Nanjing Normal University), Lei Shen(Jiangsu University), Xiang Cao(Jiangsu University)
British Journal of Pharmacology
January 29, 2014
Cited by 69


Related Papers